The involvement of caspases in apoptosis after spinal cord injury (SCI) was investigated in adult mouse spinal cord after contusion. Sections of spinal cord were processed for staining 7 days after SCI with the fluorescent dye Hoechst 33342, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL), and immunostaining with an antibody (CM1) recognizing activated caspase-3. Caspase-3-and caspase-8-like enzyme activities were measured colorimetrically at 8 hours to 7 days after SCI using the specific substrates Asp-Glu-Val-Asp-p-nitroanilide and Ile-Glu-ThrAsp-p-nitroanilide, respectively. Hoechst 33342 staining showed small, bright areas in fragmented nuclei. Double labeling with TUNEL plus immunostaining with cell type-specific markers identified TUNEL-positive neurons stained by anti-neuronal nuclear protein/neurons antibody, and TUNEL-positive oligodendrocytes stained by anti-cyclic nucleotide 3'-phosphohydrolase antibody. Double labeling with CM1 and cell-type specific markers similarly identified CM1-positive neurons and oligodendrocytes. Caspase-8-like enzyme activity was increased significantly on days 3 and 7 (p º 0.01), whereas caspase-3-like activity increased on day 7 (p º 0.01). Intraventricular injection of a nonspecific tetrapeptide caspase inhibitor or a specific tetrapeptide inhibitor of caspase-3 just after SCI reduced enzyme activity at 7 days. Apoptotic cells were identified with TUNEL staining in both neurons and oligodendrocytes in mice after SCI, which also showed activated caspase-3. Increased caspase-3-and caspase-8-like activity was detected in the injured spinal cord on days 3 and 7. Caspase protease activities may be involved in delayed neuronal and glial apoptosis after SCI.
Introduction
Decades of investigations have greatly improved our understanding of the complex pathophysiology of spinal cord injury (SCI). The mechanism of neuronal impairment may involve primary damage due to external mechanical force and additional damage representing secondary degeneration initiated from the site of the primary damage. 4, 6, 17, 21, 42, 43) Apoptotic cells are present in injured spinal cord, suggesting that degeneration at the mechanically damaged site and delayed demyelination of tracts at a distance from the injury might be partly due to apoptosis. 13, 26, 31, 34, 38, 50) Apoptosis is one of the two types of cell death: necrosis occurs in a matter of seconds; whereas apoptosis or programmed cell death is a much slower process, representing a series of events over a few hours to several days, depending on the initiating stimulus. Apoptosis is characterized ultrastructurally by degradation of nuclear chromatin, condensation of the cytoplasm and nucleus, and ultimately fragmentation of the cell into apoptotic bodies. 11, 27) These distinct changes in cellular structure differ sharply from those seen in necrosis.
Apoptosis requires activation of a cysteine protease enzyme that cleaves peptides at a position next to an aspartyl residue. 3, 14) This family of cysteine aspartyl proteases, now numbering 14, are called the caspases, and shows similarities to the product of ced-3, an essential cell death gene in Caenorhabditis elegans. Caspases can be divided into two main groups: initiators (caspase-1, -2, -8, and -9) and effectors such as caspase-3. Current evidence suggests that several distinct routes can lead to caspase activation depending upon the stimulus that cleaves the initiator enzyme. Such initiation activates caspase-3 and induces apoptosis. Caspases are all expressed as proenzymes including three domains: the N-termi-nal domain, a large subunit of approximately 20 kDa (p20), and a small subunit of approximately 10 kDa (p10). After activation, the proenzyme is cleaved at consensus sites into p20 and p10 subunits and then forms a catalytic tetramer. 44) The present study investigated the molecular mechanisms of neuronal and glial apoptosis after SCI using immunohistochemistry to confirm the occurrence of neuronal and glial apoptosis and investigate the temporal and regional profiles of caspase-3-and caspase-8-like enzyme activities, and the effect of early administration of a nonspecific tetrapeptide caspase inhibitor, Z-Val-Ala-Asp-fluoromethyl ketone (Z-VAD-fmk), or a specific caspase-3 inhibitor, Z-Asp-Glu-Val-Asp-fluoromethyl ketone (Z-DEVD-fmk), on caspase enzyme activity at 7 days after SCI.
Materials and Methods

I. SCI model
Young adult female C57BL/6 mice 11 to 12 weeks of age weighing 18 to 24 g were purchased from Shizuoka Laboratory Animal Center (Shizuoka). Anesthesia was induced with 1.5% halothane and maintained with 1.2% halothane in 60% N 2 O and 40% O 2 using an Aika Elite 80 D anesthesia machine (ACOMA Co., Ltd., Tokyo) for laboratory animals.
A dorsal operative site was shaved and wiped with iodine solution, the vertebral column was exposed, and a two-level laminectomy was performed at T-9 and T-10 without disturbing the dura. Spinal cord contusion was produced by a weight-drop method using a modification of the Allen technique. 2,28) A 2.5-g rod with a tip 1.1 mm in diameter was dropped from a height of 2 cm (5 g・cm of force) through a nylon tube of 1.2 mm inner diameter, directly onto the dura overlying the cord to cause moderate SCI. After the weight drop, the wound was closed in layers. All contusive injuries occurred in a dry surgical field. Rectal temperature was maintained at about 379 C with a thermostatically controlled heating device during the surgical procedure.
The bladder was emptied manually twice daily until return of reflexive bladder control; in most animals this occurred within 1 week. At various intervals after injury, animals were decapitated after injection of sodium pentobarbital (100 mg/kg, i.p.), and the spinal cord was removed rapidly. Naive control animals received no anesthesia or surgery. Sham-operated control animals underwent anesthesia and laminectomy but no trauma. Tissue samples were obtained at 8, 24, and 72 hours and at 7 days after SCI to measure caspase enzyme activity as described below. Immunohistochemistry tissue samples and tissue samples to evaluate caspase inhibition in vivo were obtained 7 days after SCI.
All protocols were approved by the Institute for Laboratory Animal Research, Nagoya University School of Medicine.
II. Neurological score
The neurological deficit caused by the SCI was assessed using a modified Tarlov scale, ranging from 0 (flaccid paralysis) to 5 (normal walking). 41) This scale was subdivided to more accurately reflect the pattern of recovery of locomotor function as follows: 0, no spontaneous movement; 1, movement of an involuntary nature or movement at the hip or knee but not the ankle; 2, movement of the hindlimb at all three major joints; 3, active support of an uncoordinated gait; 4, coordination of forelimbs and hindlimb gait (trotting), including some walking on the knuckles or on the medial surface of the foot or walking with a few toes dragging; and 5, normal locomotion. Animals were included in the study only if the neurological score was 0 or 1 just after SCI.
III. Immunohistochemistry
Mice were sacrificed with an overdose of sodium pentobarbital (100 mg/kg, i.p.) at 7 days after SCI (n ＝ 10). After rapid removal, the spinal cord was frozen in Tissue Tek embedding compound (Sakura Fine Technical, Tokyo) and stored at -809 C. Frozen sections of 16 mm thickness were cut with a cryostat (CRYOCUT 1800; Leica, Weltzlar, Germany). Sections were placed on silanized slides (DAKO Japan, Kyoto), dried for 30 minutes in a desiccator, and stored at -309 C until use.
IV. Hoechst 33342 staining
Frozen sections (n ＝ 3) of the lesion site were stained with the fluorescent dye Hoechst 33342 (bisbenzamide; Sigma, St. Louis, Mo., U.S.A.) at 10 mg/ml in phosphate-buffered saline (PBS) for 5 minutes, washed three times in PBS, placed under a coverslip in aqueous mounting medium (Vector Laboratories, Burlingame, Calif., U.S.A.), and examined using a Zeiss Axiovert 135 microscope (Carl Zeiss, Oberkochen, Germany) with ultraviolet excitation and a filter to detect fluorescein isothiocyanate (FITC) fluorescence.
V. Nick-end labeling
Sections were fixed in 10% neutral buffered formalin for 10 minutes, washed in PBS, incubated in ethanol-acetic acid (2:1) for 5 minutes at -209 C, and washed again in PBS, then incubated with 20 mg/ml of proteinase K (Sigma) for 5 minutes to remove nuclear proteins. Terminal deoxynucleotidyl trans-
ferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) was accomplished using the ApopTag in situ labeling kit (Oncor, Gaithersburg, Md., U.S.A.). After immersion in equilibration buffer for 10 minutes, sections were incubated with terminal deoxynucleotidyl transferase and deoxyuridine triphosphate-digoxigenin in a humid chamber at 379 C for 1 hour and then incubated in stop/wash buffer at 379 C for 30 minutes. Sections were washed with PBS twice before incubation in anti-digoxigenin antibody conjugated with peroxidase for 30 minutes at room temperature. After washing, bound peroxidase was visualized and the section was counterstained with hematoxylin. Deoxyribonucleasetreated sections of reactive lymph nodes were used as positive controls.
VI. TUNEL and immunohistochemistry double staining
The types of cells undergoing deoxyribonucleic acid (DNA) fragmentation were identified by TUNEL labeling combined with immunohistochemical staining for neurons using monoclonal antineuronal nuclear protein/neuron (NeuN) antibody After washing in TPBS, sections were mounted in aqueous mounting medium (Vectashield; Vector Laboratories) and examined using a Zeiss Axiovert 135 microscope with ultraviolet excitation and a filter to detect FITC fluorescence.
VII. Caspase-3 (CM1) staining
Activation of caspase-3 in injured spinal cord was determined using CM1 antibody to detect caspase-3 cleavage products. The CM1 antibody was generated against the C-terminal propeptide of CPP32 and was affinity purified. The antibody selectively recognizes the p 18 kDa cleavage product, not the inactive proform of caspase-3, and was used previously to detect activated caspase-3 in a variety of model systems. 8, 30, 33, 36, 40) CM1 antibody was a generous gift from IDUN Pharmaceutical (La Jolla, Calif., U.S.A.).
Sections were fixed in 10% neutral buffered formalin for 10 minutes, washed in PBS, and exposed at -209 C to ethanol-acetic acid (2:1) for 5 minutes, then incubated with blocking buffer (2% bovine serum albumin [BSA], 0.2% nonfat milk powder, 2% normal goat serum [NGS] , and 0.8% Triton X-100 in PBS) for 1 to 2 hours at room temperature, and then with the primary antibody CM1 at 1:2000 dilution in antibody incubation buffer (2% NGS and 0.4% Triton X-100 in PBS) for 1 to 2 hours at room temperature. Sections were then washed three times with TPBS, followed by incubation for 2 hours at room temperature with biotinylated goat anti-rabbit IgG (Vector Laboratories) in PBS (pH 7.4), containing 2% NGS and 0.3% Triton X-100. After washing three times in PBS, sections were incubated with avidin-biotin-peroxidase solution (Vectastain Elite ABC kit; Vector Laboratories) in PBS for 30 minutes at room temperature. After three additional washes in PBS, the sections were incubated in 3-amino-9-ethylcarbazole (AEC) (AEC substrate kit for peroxidase; Vector Laboratories) according to the manufacturer's protocol. The sections were counterstained with hematoxylin and then mounted in aqueous medium.
VIII. Caspase-3 (CM1) double staining
Cell types expressing caspase-3 were identified by CM1 staining combined with immunohistochemical staining to detect neurons or oligodendrocytes using the same primary antibodies as described before. Sections were rinsed with TPBS, then incubated with mouse IgG, rinsed with TPBS, and incubated with mouse IgG blocking solution (MOM Immunodetection kit) and with blocking buffer (2% BSA, 0.2% nonfat milk powder, 2% NGS, and 0.8% Triton X-100 in PBS) for 1 to 2 hours at room temperature. Sections were then incubated overnight (18 to 20 hrs) at 49 C with the primary antibodies. Sections were washed in TPBS and incubated at room temperature for 1 hour with FITC-conjugated goat anti-mouse IgG (1:50 dilution; MBL) as the secondary antibody to detect NeuN or CNP antibody immunoreactivity. After washing in TPBS, sections were incubated at room temperature for 1 hour with Texas red-conjugated goat anti-rabbit IgG (1:50 dilution; Vector Laboratories) to detect CM1 immunoreactivity. The sections were washed in TPBS, mounted, and examined as for sections with TUNEL double staining.
IX. Protease activity assay
Measurements of caspase-3-and caspase-8-like protease activity in spinal cord extracts were performed using a colorimetric protease assay kit (MBL). 22) Mice were anesthetized deeply with an overdose of sodium pentobarbital (100 mg/kg, i.p.) at 8, 24, and 72 hours (n ＝ 12 per time point) and 7 days (n ＝ 10) after SCI. Naive spinal cords were obtained as a control (n ＝ 4). Other control spinal cords were obtained at 8, 24, and 72 hours and 7 days after sham operation without SCI (n ＝ 3 at each time). The removed spinal cord was sampled as three adjacent 1.5-mm segments (rostral, lesion center, and caudal), which were stored at -209 C until use. Pooled tissue samples were homogenized in 100 ml of cell lysis buffer, allowed to stand on ice for 10 minutes, and then centrifuged at 13,000 × g for 5 minutes. Protein concentration in the supernatant was determined by standard methods (DC protein assay kit; Bio-Rad, Hercules, Calif., U.S.A.), and the supernatant was diluted to 50 mg of protein per 50 ml of lysis buffer for each assay. Then 50 ml of 2× reaction buffer containing 10 mM dithiothreitol (DTT) was added to each sample. One of the following two substrates was used to assay activity: Asp-Glu-ValAsp-p-nitroanilide (DEVD-pNA) for caspase-3-like protease activity, or Ile-Glu-Thr-Asp-p-nitroanilide (IETD-pNA) for caspase-8-like protease activity. Five microliters of a 4-mM solution of the substrate (200 mM final concentration) was incubated at 379 C for 1 hour with each sample. Enzyme-catalyzed release of p-nitroanilide was measured at 405 nm with a spectrophotometer (UV 1200; Shimazu, Kyoto). One unit of protease activity corresponded to the caspase-like activity that cleaved 1 pmol of pNA/min at 379 C at a saturated substrate concentration.
X. In vivo inhibition of protease activity Z-DEVD-fmk (MBL), a peptide methylketone caspase-3 inhibitor, was dissolved in 2% dimethyl sulfoxide (DMSO) at a concentration of 240 ng/ml. Z-VAD-fmk (MBL), a nonspecific peptide methylketone caspase inhibitor, was dissolved in DMSO at a concentration of 120 ng/ml. Peptide was injected using a 10-ml Hamilton syringe (Hamilton, Reno, Nev., U.S.A.) through a preimplanted 21G cannula into the right cerebral ventricle. The implantation site was -0.9 mm lateral and 0.1 mm posterior to the bregma. Implantation depth was 3.1 mm. Each animal received one injection of 2 ml immediately after SCI. The control SCI animals were treated only with 2% DMSO (n ＝ 5).
The doses of Z-VAD-fmk and Z-DEVD-fmk used in the present experiment were suggested by previous focal ischemia studies. 24, 36) For measurement of protease activity in peptide-injected spinal cords, the spinal cord was quickly removed 7 days after SCI and processed for the enzyme assay as described above. Since no regional differences in caspase activity were evident, the in vivo inhibition effect was assessed in a 4.5-mm block including all three regions.
XI. Statistical analysis
The mean values of caspase activities in the SCI animals were compared with that in the naive control animals using one-way analysis of variance followed by a post hoc Dunnett's test. A p value of º0.05 was considered statistically significant. All values are means ± SD.
Results
I. Effects of SCI
SCI animals had a locomotor deficit immediately upon awakening from anesthesia. Neurological scores remained significantly low for 1 week (Tarlov scale 0.87 ± 0.76). Sham-operated mice presented with no neurological deficit.
There was no histological abnormalities in the spinal cords of sham-operated mice. Spinal cord damage was mainly observed in the dorsal funiculus and posterior horn following SCI. Inflammatory cells including microglia were mainly seen at the lesion site (not illustrated).
II. Histochemical findings
Hoechst 33342 staining: Hoechst 33342 staining depicted healthy, oval-shaped nuclei possessing diffuse chromatin distribution in naive control animals (Fig. 1A) . In contrast, various stages of apoptotic change including condensed chromatin, and irregularly shaped nuclei and formation of apoptotic bodies were detected at 7 days after SCI. Hoechst 33342 staining typically demonstrated small, bright, fragmented areas in the nuclei. Cells containing apoptotic-appearing nuclei also exhibited evidence of cytoplasmic shrinkage. The nuclei generally demonstrated chromatin condensation or aggregation into small, dark nuclear fragments (Fig. 1B) .
TUNEL staining and immunohistochemistry double staining: Naive control spinal cord contained few cells with TUNEL staining or apoptotic morphology (not illustrated). Injured spinal cord had increased numbers of TUNEL-positive cells in the white matter. Double-labeling experiments combining TUNEL and immunohistochemistry revealed TUNEL labeling in neurons at the lesion site (immunohistochemical staining for neurons using NeuN antibody) (Fig. 1C, D) and in oligodendrocytes in the white matter (immunohistochemical staining for oligodendrocytes using CNP antibody), suggesting apoptosis of both neurons and oligodendrocytes (Fig. 1E, F) . Neuronal apoptosis was mainly seen in small neuron in the intermediate gray matter. On the other hand, large motoneurons were preserved in the ventral horn. However, only a small number of large motoneurons were stained with TUNEL at the lesion site. Caspase-3 (CM1) staining and immunohistochemistry double staining: Naive control spinal cord had no CM1-positive cells. CM1-positive cells were demonstrated as dark, shrunken cells containing clumped chromatin with staining for activated caspase-3 within the nucleus in the white matter near the ventral horn in injured spinal cord at 7 days after SCI (Fig. 2A, B) . Double immunofluorescence also detected the presence of activated caspase-3 in neurons as anti-NeuN-positive cells (Fig. 2C, D) , oligodendrocytes as CNP antibody-positive cells (Fig. 2E, F) , and astrocytes (not illustrated). Caspases and Apoptosis Following SCI III. Changes in caspase-3 and caspase-8 protease activities after SCI Lysates from naive spinal cords (n ＝ 4) showed low peptide cleavage activities for both DEVD-pNA (caspase-3-like) and IETD-pNA (capase-8-like) substrates, and were considered to be nonspecific background. Lysates from the rostral, lesion site, and caudal tissue blocks from injured spinal cord exhibited significant increases in caspase-8-like enzyme activity on days 3 and 7 (n ＝ 12 for 8, 24, and 72 hrs; n ＝ 10 for 7 days, p º 0.01); and a significant increase in caspase-3-like enzyme on day 7 (p º 0.01) (Fig. 3) . No significant regional differences in caspase activity were found between the three adjacent 1.5-mm tissue blocks. Lysates from the sham-operated animals showed low levels of enzyme activity at each time point (data not shown). (Fig. 4A, B) . The inhibitory effect of Z-DEVD-fmk was relatively weak (Fig. 4C, D) .
IV. Effects of inhibition
Discussion
The present study demonstrated by immunohistochemical double staining that apoptotic cell death occurred in both neurons and oligodendrocytes, and that activated caspase-3 was present in both cell types at 7 days after SCI. Colorimetric assay showed an increase in caspase-8-like activity in spinal cord homogenates after SCI preceded an increase in caspase-3-like activity. Intraventricular injection of a tetrapeptide inhibitor (Z-VAD-fmk or Z-DEVD-fmk) inhibited caspase activity at 7 days after SCI. These results strongly suggest that caspase proteases act as inducible cell death effectors in the spinal cord after traumatic injury.
Spinal cord cell death following injury results partly from apoptosis, as determined by morphological, electrophoretic, and TUNEL methods. 13, 26, 31, 34, 50) Apoptotic cell death occurs in both neurons and oligodendrocytes, and apoptosis is prominent in the white matter where wallerian degeneration occurs. 13, 34) Loss of oligodendrocytes due to apoptosis in the damaged spinal cord is relatively widespread, occurring even at considerable distances from the initial compression injury. 32) The present study confirmed that apoptotic cell death occurred in both neurons and oligodendrocytes at 7 days after SCI. Moreover, expression of activated caspase-3 (CM1) was detected in both neurons and oligodendrocytes. These results suggest that neuronal and glial apoptotic cell death is caused by induction of the caspase cascade.
Apoptosis can be induced by a variety of stimuli, but execution of the apoptotic program involves a common mechanism that relies on activation of the caspases, which are cysteine proteases belonging to the interleukin-1-converting enzyme/CED-3 family. The roles of individual caspases and their relative importance in apoptosis have recently been clarified. 42) Caspase-8 and caspase-10 are activated early in the apoptotic process and are considered initiators, whereas caspase-3 and caspase-7 are activated at a later phase of apoptosis and function as effectors that act upon a large number of substrates. Cell death receptor-induced pathways of apoptosis require activation of caspase-8 and caspase-3, whereas apoptosis following growth factor deprivation and stress-induced cell injury appears to occur via mitochondrial dysfunction with release of cytochrome c, which triggers activation of caspase-9 and then caspase-3. 1, 20, 23, 29, 30, 44, 46) In addition, apoptosis may be mediated through poorly understood caspaseindependent pathways. 48) Little is known about upstream initiating steps promoting caspase activation in the traumatized spinal cord, either receptor-or non-receptor-driven. SCI in rats causes an increase in the cytosolic level of cytochrome c within 30 minutes after injury which persists for at least 24 hours, indicating rapid transduction of cell-death signals to the mitochondria. 39) Caspase-9 activation was detected within 30 minutes after injury, and caspase-3 enzyme activity increased within 1 hour after injury, and both remained high for up to 24 hours. A 17-fold increase in caspase-1 activation occurs 24 hours after SCI in a mouse model. 33) In our study, no increase in caspase-8-like activity was noted until day 3. Caspase-8 activation might occur upstream of caspase-3 activation via pathways induced by cell-death receptors such as tumor necrosis factor (TNF) receptors. The present experiments demonstrated the temporal profile of caspase-8 and caspase-3 activity in the mouse SCI model. Delay of caspase-3 activation until 7 days after SCI indicates delayed transduction of cell death signals mediated through receptors as previously suggested. 13) The intracellular and receptormediated programmed cell death pathways contribute to a long time course of secondary injury processes after SCI. The time courses of caspase enzyme activities in our study differed from those reported previously, possibly reflecting differences in severity of SCI. 33, 39) In a severe transient focal ischemia model, only 6 hours separate the insult from detectable DNA fragmentation, but 1 to 3 days are required after mild transit focal ischemia. 16, 24) The SCI in our study was relatively mild, which may have delayed apoptosis.
TNFa may be important in apoptosis after SCI, given that caspase-8 is activated by TNFa through recruitment of the TNF receptor-associated death domain/Fas-associated death domain protein to TNF receptor-1. 5) Early induction of TNFa has been well documented in SCI. 47) In addition, activated microglia can secrete cytokines such as TNFa as well as reactive oxygen intermediates and nitric oxide. 19) Local production of TNF by glia in the central nervous system (CNS) can potently and selectively induce oligodendrocyte apoptosis and myelin degeneration in the context of an intact blood-brain barrier and absence of immune cell infiltration into the CNS parenchyma. 1) Apoptotic cells without microglial contact are located near the lesion center following SCI in rats, whereas apoptotic cells with microglial contact are found remote from the lesion center. 38) The microglia may be activated in response to degenerating axons and may cause the apoptotic death of oligodendrocytes in the white matter following SCI. Alternatively, apoptosis of remote oligodendrocytes might be initiated by withdrawal of trophic factors after axonal loss. 7) Transient spinal cord ischemia induced the formation of a death-inducing signaling complex, which might participate in caspase-8 activation and sequential caspase-3 cleavage. 35) The regional profile of the activity of caspases after SCI is unclear. Apoptotic cells after SCI are widely distributed at 8 days after SCI in rats, especially in regions closely rostral and caudal to the lesion site. 12, 13) Apoptosis of oligodendrocytes is associated with wallerian degeneration of the long spinal tracts. Signs of wallerian degeneration occur in the white matter and spread rostrally and caudally to the lesion, with the most advanced degeneration involving ascending tracts. 15) In contrast, our results demonstrated no significant regional differences in caspase activity after SCI, probably because the tissues compared taken from adjacent 1.5-mm blocks.
The present study found that early in vivo administration of caspase inhibitors Z-VAD-fmk and Z-DEVD-fmk inhibited caspase activity in mice at 7 days after SCI. Z-VAD-fmk reduced the caspase activities more effectively than Z-DEVD-fmk, probably because the former is a nonselective inhibitor of activated caspases and also can suppress the inflammatory process following SCI. Z-VAD-fmk can block secondary injury events such as cytokine cascades more effectively than Z-DEVD-fmk. These results are in agreement with a previous study showing that nonselective cysteine protease inhibitors may be more effective in reducing apoptosis in an ischemic model than those showing greater selectivity. 24) A single intraventricular injection of Z-DEVD-fmk, a relatively selective caspase-3 inhibitor, is effective if given 9 hours after 30 minutes of reversible ischemia in mice 18) or 3 hours after neonatal hypoxic-ischemia in rats. 10) Cell protection may persist for at least 22 days. 18) Such long-lasting inhibition of caspase activity is thought to result from irreversible alkylation of a cysteine sulfhydryl group at the active sites. 45) Regulation of apoptosis after SCI may be useful for reducing tissue damage from secondary injury and ultimately improving the functional outcomes. Intraperitoneal injections of cycloheximide, a protein synthesis inhibitor, improved behaviorally assessed outcomes after spinal cord contusion injury in rats. 34) Tetrapeptide caspase inhibitors can reduce apoptosis after other types of CNS injury. 9, 18, 24, 36, 49) Caspases are involved in the TNF-mediated death of oligodendrocytes and inhibition of these proteases can prevent apoptosis. 25) Pharmacological inhibition with Z-VAD-fmk significantly blocked activation of both caspase-1 and caspase-3 and decreased the extent of SCI-induced apoptosis in a mouse model. 33) Treatment of the contused spinal cord with the interleukin-1 receptor antagonist using osmotic minipump completely abolished the increase in contusion-induced apoptosis and caspase-3 activity. 37) The weight-drop method in the mouse SCI model produces a reproducible functional deficit that correlates with the histological findings. 28) In combination with a variety of well-studied genetic mutations or gene technologies applicable to mice, this model may provide a unique opportunity for in vivo determination of the contribution of specific proteins and other molecules to SCI and subsequent recovery.
In conclusion, increases in caspase-3-and caspase-8-like activity occurred in mice after SCI. Immunohistochemical study detected activated caspase-3 in both neurons and oligodendrocytes. These results strongly implicate the prolonged apoptotic cascade activation in the mechanism of SCI and support further development of pharmacological and molecular therapies targeting apoptosis after SCI, stroke, and other types of CNS injury.
Commentary
In this paper, Takagi et al. report the involvement of caspase 3 and 8 in delayed apoptosis of neurons and oligodendrocytes after spinal cord injury (SCI). They found that the inhibition of caspase synthesis or activity decreased the extent of SCI-induced apoptosis and anticipate the development of pharmacological and molecular therapies targeting apoptosis after SCI. Recently, Ozawa et al. investigated new therapeutic strategies targeting caspase inhibition following SCI in rats. They detected no significant differences in locomotor function and contusion volume between rats treated with broad specific caspase inhibitor via various routes and animals treated with only vehicle. 1) Further studies to support the development of strategies targeting apoptosis after SCI are necessary.
